The past 15 years have seen a rapid increase in the introduction of drug-device combination products driven by a move towards more self-medication. This has included the adoption of a relatively small number of electronic drug delivery devices but with the arrival of low cost wireless connectivity, there is an opportunity to accelerate the adoption of new technology and introduce digital services that can provide better patient support, either by enabling patients to take more control of their medication and disease management to provide remote access to healthcare support. The Covid situation has impacted us in many ways over the past 18 months and for medication and disease management, it has demonstrated both the need and the potential for telemedicine and remote monitoring.